KNSA
NASD Kiniksa Pharmaceuticals International, plc Class A$79.78 ↑ +0.00 (+0.00%) Trading Up from the previous close of $79.78, $0.72 below the day’s high of $80.50
- YTD change
- +93.41%
- vs 20-day SMA
- +4.13%
- vs 200-day SMA
- +40.15%
Price ranges
Price & Performance
+32.70 (+69.46%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 3.8% away from all-time highs of $82.94
- KNSA is up 93% since the beginning of the year
- KNSA is up 109% over the past 12 months
- KNSA is up 4% over the past 1 month
- 8% of all KNSA investors are betting against KNSA
KNSA reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +110.6%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +6.06%
- vs 8-day SMA
- +4.38%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
